Proteases implicated in apoptosis: Old and new

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 5, 2010, Pages 563-576

  Moffitt, Kelly L ^a   Martin, S Lorraine ^a   Walker, Brian ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Apoptosis; Diphenyl phosphonate; Protease; Proteolytic; Serine

Indexed keywords

ASPARTIC PROTEINASE; AUTOPHAGY PROTEIN 5; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CALPAIN; CALPASTATIN; CASPASE; CASPASE INHIBITOR; CATHEPSIN; CYSTATIN; CYSTEINE PROTEINASE; GRANZYME A; GRANZYME B; LACTACYSTIN; METALLOPROTEINASE; PROTEASOME; PROTEINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE OMI; STEFIN; THREONINE PROTEINASE; THROMBIN; X LINKED INHIBITOR OF APOPTOSIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; APOPTOSIS; CANCER INVASION; CLINICAL TRIAL; EXTRACELLULAR MATRIX; HUMAN; MACROPHAGE; METASTASIS; MULTIPLE MYELOMA; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; REVIEW; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION;

APOPTOSIS; HUMANS; PEPTIDE HYDROLASES; SERINE PROTEASES;

EID: 84940570573     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.05.0002     Document Type: Review

References (148)

1. Shinohara K et al. Apoptosis induction resulting from Proteasome inhibition. J Biochem 1996 317 : 385 388.
2. Abate A, Schroder H. Protease inhibitors protect macrophages from lipopolysaccharide-induced cytotoxicity: possible role for NF- kappa B. Life Sci 1998 62 : 1081 1088.
3. Grabarek J, Darzynkiewicz Z. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors. Exp Hematol 2002 30 : 982 989.
4. Chen C et al. A novel serine protease predominately expressed in macrophages. J Biochem 2003 374 : 97 107.
5. O'Connell AR et al. Characterization of a serine protease-mediated cell death program activated in human leukemia cells. Exp Cell Res 2006 312 : 27 39.
6. Sanchez EF et al. Handbook of Proteolytic Enzymes, 2nd edn.
7. Barrett AJ. Proteases. Encyclopedia of Life Sciences, http://www.els.net.
8. Chapman HA et al. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997 59 : 63 88.
9. Seemuller E et al. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995 268 : 579.
10. Barrett AJ, Rawlings ND. Families and clans of serine peptidases. Arch Biochem Biophys 1995 318 : 247 250.
11. Di Cera E, Krem MM. Serine proteases. Encyclopedia of Life Sciences, http://www.els.net.
12. Stenson-Cox C et al. In the cut and thrust of apoptosis, serine proteases come of age. Biochem Pharmacol 2003 66 : 1469 1474.
13. Rawlings ND, Barrett AJ. Families of serine peptidases. Methods Enzymol 1994 244 : 19 61.
14. Lesk AM, Fordham WD. Conservation and variability in the structures of serine proteinases of the chymotrypsin family. J Mol Biol 1996 258 : 501 537.
15. Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci 1995 4 : 337 360.
16. Bird PI. Serpins and regulation of cell death. Results Probl Cell Differ 1998 24 : 63 89.
17. Chang C, Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001 11 : S37 43.
18. Ray JM, Stetler-Stevenson WG. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 1994 7 : 2062 2072.
19. Sternlicht MD, Werb Z. How metalloproteases regulate cell behaviour. Annu Rev Cell Dev Biol 2001 17 : 463 516.
20. Debouck C et al. Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Nat Acad Sci U S A 1987 84 : 8903 8906.
21. Fujinaga M et al. The molecular structure and catalytic mechanism of a novel carboxyl peptidase from Scytalidium lignicolum. Proc Nat Acad Sci U S A 2004 101 : 3364 3369.
22. Sims AH et al. Glutamic protease distribution is limited to filamentous fungi. FEMS Microbiol Lett 2004 239 : 95 101.
23. Castino R et al. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas. Int J Cancer 2002 97 : 775 779.
24. Johnson DE. Noncaspase proteases in apoptosis. Leukemia 2000 14 : 1695 1703.
25. Gong B et al. Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of cysteine and serine proteases. Cell Growth Diff 1999 10 : 491 502.
26. Egger L et al. Serine proteases mediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death Diff 2003 10 : 1188 1203.
27. Yousefi S et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006 8 : 1124 1132.
28. Saito K et al. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 1993 90 : 2628 2632.
29. Deiss LP et al. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 1996 15 : 3861 3870.
30. Wu GS et al. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998 16 : 2177 2183.
31. Shibata M et al. Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun 1998 251 : 199 203.
32. Guicciardi ME et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000 106 : 1127 1137.
33. Zhu D-M, Uckun FM. Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells. Clin Cancer Res 2000 6 : 2064 2069.
34. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000 62 : 273 295.
35. Makarewicz R et al. Cathepsin B in predicting the extent of the cervix carcinoma. Neoplasma 1995 42 : 21 24.
36. Garcia M et al. Biological and clinical significance of cathepsin D in breast cancer metastasis. Stem Cells 1996 14 : 642 650.
37. Flannery T et al. The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol 2003 163 : 175 182.
38. Flannery T et al. Cathepsin S expression: an independent prognostic factor in glioblastoma tumours-a pilot study. Int J Cancer 2006 119 : 854 860.
39. Emert-Sedlak L et al. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death. Mol Cancer Ther 2005 4 : 733 742.
40. Cataldo AM et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995 14 : 671 680.
41. Roberts LR et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 1997 113 : 1714 1726.
42. Felbor U et al. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc Natl Acad Sci U S A 2002 99 : 7883 7888.
43. Michallet MC et al. Cathepsin-dependent apoptosis triggered by supraoptimal activation of T lymphocytes: a possible mechanism of high dose tolerance. J Immunol 2004 172 : 5405 5414.
44. Li W et al. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. Arterioscler Thromb Vasc Biol 1998 18 : 177 184.
45. Roberg K, Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998 152 : 1151 1156.
46. Vancompernolle K et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 1998 438 : 150 158.
47. Johansson AC et al. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003 10 : 1253 1259.
48. Blomgran R et al. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukocyte Biol 2007 81 : 1213 1223.
49. Nishimura Y et al. Identification of latent procathepsins B and L in microsomal lumen: characterization of enzymatic activation and proteolytic processing in vitro. Arch Biochem Biophys 1988 61 : 64 71.
50. Rowan AD et al. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J Biol Chem 1992 267 : 15993 15999.
51. Stoka V et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001 276 : 3149 3157.
52. Zhou Q, Salvesen GS. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem J 1997 324 : 361 364.
53. Zhu DM, Uckun FM. Cathepsin inhibition induces apoptotic death in human leukemia and lymphoma cells. Leuk Lymphoma 2000 39 : 343 354.
54. Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991 285 : 213 219.
55. van Nierop K et al. Lysosomal destabilization contributes to apoptosis of germinal center B-lymphocytes. J Histochem Cytochem 2006 54 : 1425 1435.
56. Turk B et al. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997 378 : 141 150.
57. Lindahl P et al. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem J 1992 281 : 49 55.
58. Langerholc T et al. Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J 2005 272 : 1535 1545.
59. Dickinson DP. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002 13 : 238 275.
60. Cohen GM. Caspases: the executioners of apoptosis. J Biochem 1997 326 : 1 16.
61. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998 281 : 1312 1316.
62. Komiyama T et al. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 1994 269 : 19331 19337.
63. Deveraux QL et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997 388 : 300 304.
64. Roy N et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997 16 : 6914 6925.
65. Xue D, Horvitz HR. Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein. Nature 1995 377 : 248 251.
66. Bump NJ et al. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 1995 269 : 1885 1888.
67. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev 1999 13 : 239 252.
68. Clem RJ, Miller LK. Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 1994 14 : 5212 5222.
69. Eytan E et al. ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to Ubiquitin. Proc Natl Acad Sci U S A 1989 86 : 7751 7755.
70. Peters JM et al. Structural features of the 26 S proteasome complex. J Mol Biol 1993 234 : 932 937.
71. Peters JM et al. Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 1994 269 : 7709 7718.
72. Crawford LJ et al. Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132. Cancer Res 2006 66 : 6379 6386.
73. Groll M et al. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 1997 386 : 463 471.
74. Hochstrasser M. Ubiquitin-dependent protein degradation. Ann Rev Genet 1996 30 : 405 439.
75. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr Opin Cell Biol 1997 9 : 788 799.
76. Pickart CM. Targeting of substrates to the 26S proteasome. FASEB J 1997 11 : 1055 1066.
77. Coux O et al. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996 65 : 801 847.
78. Baumeister W, Lupas A. The proteasome. Curr Opin Struct Biol 1997 7 : 273 278.
79. Zhang X-M et al. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. J Biochem 1999 340 : 127 133.
80. Fujiwara T et al. Proteasomes are essential for yeast proliferation. cDNA cloning and gene disruption of two major subunits. J Biol Chem 1990 265 : 16604 16613.
81. Imajoh-Ohmi S et al. Lactacystin, a specific inhibitor of the Proteasome, induces apoptosis in human monoblast U937 Cells. Biochem Biophys Res Commun 1995 217 : 1070 1077.
82. Grimm LM et al. Proteasomes play an essential role in thymocyte apoptosis. EMBO J 1996 15 : 3835 3844.
83. Fenteany G et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995 268 : 726 731.
84. Almond JB, Cohen GM. The proteasome: a novel target for cancer chemotherapy. Leukemia 2002 16 : 433 443.
85. Kane RC et al. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 2003 8 : 508 513.
86. Lynas JF et al. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals). Bioorg Med Chem Lett 1998 8 : 373 378.
87. Walker B et al. Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases. Biochem J 1993 293 : 321 323.
88. Andersson M et al. Caspase and proteasome activity during staurosporine-induced apoptosis in lens epithelial cells. Invest. Ophthalmol Vis Sci 2000 41 : 2623 2632.
89. Ruggiero V et al. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell Immunol 1987 107 : 317 325.
90. Williams MS, Henkart PA. Apoptotic cell death induced by intracellular proteolysis. J Immunol 1994 153 : 4247 4255.
91. Dong Z et al. Serine protease inhibitors suppress cytochrome c-mediated caspase-9 activation and apoptosis during hypoxia-reoxygenation. Biochem J 2000 347 : 669 677.
92. O'Connell AR et al. Caspase-dependant activation of chymotrypsin-like proteases mediates nuclear events during Jurkat T cell apoptosis. Biochem Biophys Res Commun 2006 345 : 608 616.
93. Murn J et al. Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease. Genes Cells 2004 9 : 1103 1111.
94. Trapani, Granzymes JA. a family of lymphocyte granule serine proteases. Genome Biol 2001 2 : 3014.1 3014.7.
95. Alimonti JB et al. Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J Biol Chem 2001 276 : 6974 6982.
96. Thornberry NA et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997 272 : 17907 17911.
97. Pasternack MS et al. Granzyme A binding to target cell proteins. Granzyme A binds to and cleaves nucleolin in vitro. J Biol Chem 1991 266 : 14703 14708.
98. Irmler M et al. Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med 1995 181 : 1917 1922.
99. Hayes MP et al. Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 1989 170 : 933 946.
100. Wright SC et al. Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med 1997 186 : 1107 1117.
101. Hegde R et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002 277 : 432 438.
102. Spiess C et al. A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 1999 97 : 339 347.
103. Vaux DL, Silke J. HtrA2/Omi, a sheep in wolf's clothing. Cell 2003 115 : 251 253.
104. Suzuki Y et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001 8 : 613 621.
105. Verhagen AM et al. HtrA2 promotes cell death through Its serine protease activity and its ability to antagonize Inhibitor of Apoptosis Proteins. J Biol Chem 2002 277 : 445 454.
106. Balow RM et al. Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver. J Biol Chem 1983 258 : 11622 11628.
107. McDonald JK, Barrett AJ. Mammalian Proteases: A Glossary and Bibliography, Vol. 2: Exopeptidases.
108. Rose C et al. Characterization and inhibition of a cholecystokinin- inactivating serine peptidase. Nature 1996 380 : 403 409. (Pubitemid 26102716)
109. Geier E et al. A giant protease with potential to substitute for some functions of the proteasome. Science 1999 283 : 978 981.
110. Macpherson E et al. Supramolecular structure of tripeptidyl peptidase II from human erythrocytes as studied by electron microscopy, and its correlation to enzyme activity. Biochem J 1987 248 : 259 263.
111. Tomkinson, B. Tripeptidyl-peptidase II. In : Barrett AJ et al., eds. Handbook of Proteolytic Enzymes, 2nd edn.
112. Gavioli R et al. c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nat Cell Biol 2001 3 : 283 288.
113. Wray CJ et al. Tripeptidyl-peptidase II expression and activity are increased in skeletal muscle during sepsis. Biochem Biophys Res Commun 2002 296 : 41 47.
114. Hasselgren PO et al. Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 2002 290 : 1 10.
115. Chand A et al. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle. Cancer Lett 2005 218 : 215 222.
116. Hilbi H et al. Tripeptidyl Peptidase II promotes maturation of caspase-1 in Shigella flexneri-induced macrophage apoptosis. Infect Immun 2000 68 : 5502 5508.
117. Hong X et al. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis. J Exp Med 2003 197 : 1731 1743.
118. Reits E et al. A major role for TPPII in trimming proteasomal degradation products for MHC Class I antigen presentation. Immunity 2004 20 : 495 506.
119. York IA et al. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation. J Immunol 2006 177 : 1434 1443.
120. Mllnarczuk I et al. AAF-cmk sensitizes tumor cells to trail-mediated apoptosis. Leuk Res 2004 28 : 53 61.
121. Thiemmara V et al. Serine protease inhibitor Spi2 mediated apoptosis of olfactory neurons. Cell Death Differ 2002 9 : 1343 1351.
122. Whitaker JR, Perez-Villasenor J. Chemical modification of papain. I. Reaction with the chloromethyl ketones of phenylalanine and lysine and with phenylmethylsulfonyl fluoride. Arch Biochem Biophys 1968 124 : 70 78.
123. Shaw E. Selective chemical modification of proteins. Physiol Rev 1970 50 : 244 296.
124. Eichinger A et al. Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J 1999 18 : 5453 5462.
125. Rozman-Pungerčar J et al. Inhibition of papain-like cysteine proteases and legumain by "caspase-specific" inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ 2003 10 : 881 888.
126. Rossman T et al. Inhibition of macromolecular synthesis in Escherichia coli by protease inhibitors. Specific reversal by glutathione of the effects of chloromethyl ketones. J Biol Chem 1974 249 : 3412 3417.
127. Tsan MF. Inhibition of neutrophil sulfhydryl groups by chloromethyl ketones. A mechanism for their inhibition of superoxide production. Biochem Biophys Res Commun 1983 112 : 671 677.
128. Shaw E et al. Evidence for an active-center histidine in trypsin through use of a specific reagent, 1-chloro-3-tosylamido-7-amino-2-heptanone, the chloromethyl ketone derived from Nα-tosyl-L-lysine. Biochemistry 1965 4 : 2219 2224.
129. Coggins JR et al. Affinity labelling of proteinases with tryptic specificity by peptides with C-terminal lysine chloromethyl ketone. Biochem J 1974 137 : 579 585.
130. Schoellmann G, Shaw E. Direct evidence for the presence of histidine in the active center of chymotrypsin. Biochemistry 1963 2 : 252 255.
131. Gillibert M et al. Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation. Biochem J 2005 386 : 549 556.
132. King MA et al. Pro- and anti-apoptotic effects of an inhibitor of chymotrypsin-like serine proteases. Cell Cycle 2004 3 : 1566 1571.
133. Kaufmann SH et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993 53 : 3976 3985.
134. Solomon DH et al. N-alpha-Tosyl-L-lysine chloromethyl ketone and N-alpha-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C. FEBS Lett 1985 190 : 342 344.
135. Kikkawa U et al. Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties. J Biol Chem 1982 257 : 13341 13348.
136. Mlejnek P. Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cells Leukemia 2005 19 : 1085 1087.
137. Finco TS et al. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A 1994 91 : 11884 11888.
138. Higuchi M et al. Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-kappa B activation, cytotoxicity, and differentiation. Blood 1995 86 : 2248 2256.
139. s6k activation. J Biol Chem 1996 271 : 23650 23652.
140. Miyamoto S et al. Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B. Proc Natl Acad Sci U S A 1994 91 : 12740 12744.
141. Lin Y et al. Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B. Proc Natl Acad Sci U S A 1995 92 : 552 556.
142. DiDonato JA et al. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 1995 15 : 1302 1311.
143. Page AE et al. Purification and characterization of a tripeptidyl peptidase I from human osteoclastomas: evidence for its role in bone resorption. Arch Biochem Biophys 1993 306 : 354 359.
144. Oleksyszyn J, Powers JC. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Biochemistry 1991 30 : 485 493.
145. Oleksyszyn J et al. Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases. J Med Chem 1994 37 : 226 231.
146. Belyaev A et al. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem 1999 42 : 1041 1052.
147. Oleksyszyn J, Powers JC. Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases. Methods Enzymol 1994 244 : 423 441.
148. De Meester I et al. In vivo inhibition of dipeptidyl peptidase IV activity by Pro-Pro-diphenyl-phosphonate (Prodipine). Biochem Pharmacol 1997 54 : 173 179. (Pubitemid 27353235)